Petlife Pharmaceuticals, Inc. engages in the research, development, sales, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases. Its products include preventative, tabs, and pet foods under the brand name Vitalzul. The company was founded on April 5, 2002 and is headquartered in Los Angeles, CA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company